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Re-engineering of nonribosomal peptide synthetase molecular assembly lines has been hampered by a lack
of detailed knowledge concerning inter-domain substrate transfer. Recent structural studies of catalytically
relevant domain-domain interactions provide valuable insights into this problem (Liu et al., 2011; Sundlov
et al., 2012 [in this issue of Chemistry & Biology]).An enormous variety of complex sec-
ondary metabolites are synthesized
in vivo by large multi-domain enzymes,
the nonribosomal peptide synthetases
(NRPSs). In contrast to ribosomal peptide
synthesis, in which the nascent peptide
sequence is translated from a messenger
RNA template via transfer RNA mole-
cules, the NRPSs function directly as
protein templates, with specific modules
responsible for adding individual building
blocks to the growing peptide chain. The
composition of the resulting product is
determined by the number and order of
NRPS modules. A typical minimal module
consists of an adenylation (A)-domain,
a condensation (C)-domain, and a pep-
tidyl carrier protein (PCP)-domain. The
A-domains, responsible for substrate
selection (and therefore ultimately pro-
duct composition), activate substrate
monomers by forming an adenylate inter-
mediate. Activated moieties are trans-
ferred to the 40-phosphopantheic acid
(PPant) cofactor thiol group of holo PCP,
which in turn can interact with upstream
and downstream C-domains, responsible
for peptide bond formation, so that the
nascent peptide chain remains attached
to a PCP thiol group. A dedicated thio-
esterase (TE) domain is often responsible
for release of the final product from the
ultimate PCP.
The biosynthesis of the Escherichia coli
iron chelator enterobactin, accomplished
by the two-module enterobactin synthe-
tase (comprising the three proteins EntE,
EntB, and EntF), nicely illustrates the
typical sequence of reactions (Figure 1A).
In the first step (1), 2,3-dihydroxybenzoic
acid (DHB) is activated to the correspond-ing adenylate by the A-domain EntE. DHB
is then transferred to the PPant side chain
of the EntB PCP by thiol ester formation
(2). In the second step, serine is activated
(3) by the corresponding EntF A-domain
and transferred to the following PCP
domain (4). The condensation domain C
then catalyzes peptide bond formation
between the thiol-bound DHB and serine
residues (5), resulting in PCP-bound
DHB-Ser. This process is repeated to
yield the linear depsipeptide (DHB-Ser)3
bound to the EntF PCP thiol group. In
the final stage (6), a TE domain catalyzes
cyclisation and release of the trimeric
macrolactone enterobactin (DHB-Ser)3.
The antibiotic, antitumor, immuno-
suppressive, or antifungal properties of
many nonribosomal peptides make them
particularly interesting for pharmaceutical
research. However, attempts to redesign
NRPSs by module shuffling have met
with limited success (for review, see
Strieker et al., 2010). A comprehensive
understanding of substrate recognition
and transfer within the NRPS assembly
line has therefore important implications
for the design of modified or novel
‘‘natural’’ products. Detailed structural
information is now available for a variety
of NRPS components (reviewed recently
by Strieker et al., 2010). The A-domain,
composed of a large N-terminal and a
small C-terminal domain connected via
a short hinge, undergoes multiple reorga-
nizations during catalysis (Gulick, 2009).
Substrate, ATP, and Mg2+ are thought to
bind to the large domain in an ‘‘open’’
conformation (c.f. Figure 1D), which leads
to closure of the small domain onto the
large domain (‘‘adenylation’’ conforma-Chemistry & Biology 19, February 24, 2012tion; Figure 1B), catalysis of adenylate
formation, and pyrophosphate release.
Possibly as a result of electrostatic distri-
bution changes (Yonus et al., 2008), the
small domain rotates some 140 to facili-
tate substrate transfer to the holo PCP
PPant thiol group (‘‘thiolation’’ conforma-
tion; see Figure 1C). The four-helix bundle
PCP-domains are surprisingly dynamic
(Koglin et al., 2006), adopting alternative
conformations in the apo and holo states.
Less is known about the structural
plasticity of the C-domains, whereas the
TE-domains possess a conformationally
variable lid domain (Bruner et al., 2002).
The large number of conformational
states available to NRPS domains make
them demanding targets for structure
determination. Whereas the apo PCP:TE
interaction could be elucidated using
NMR (Frueh et al., 2008), the sheer size
of NRPS domains poses significant
experimental challenges. Crystallization
of the entire termination module SrfA-C
(consisting of C-, A-, PCP-, and TE-
domains) of the surfactin NRPS revealed
that A- and C-domains form a contiguous
structural platform, with the (apo) PCP
domain in a position compatible with an
interaction with the C-domain (Tanovic
et al., 2008; Figure 1D).
A two-pronged approach has been
used to trap the PCP:A-domain interac-
tion (Sundlov et al., 2012 [in this issue
of Chemistry & Biology]). In addition to
fusing the stand-alone aryl acid activat-
ing domain EntE to the PCP-domain of
EntB with a four-residue linker, a mecha-
nism-based vinylsulfonamide inhibitor
was utilized, resulting in formation of a
covalent DHB-adenylate-thioether thatª2012 Elsevier Ltd All rights reserved 167
Figure 1. The NRPS Molecular Assembly Line
(A) Biosynthesis of the catechol siderophore enterobactin.
(B) A-domain adenylation conformation, based on DhbE (May et al., 2002) superimposed on the Srf A-C termination module (Tanovic et al., 2008).
(C) Thiolation conformation for transfer from the A-domain to the PCP PPant group (Sundlov et al., 2012).
(D) Putative PCP:C-domain interaction observed in the Srf A-C module (Tanovic et al., 2008); A-domain in ‘‘open’’ conformation.
(E) Domain organization for transfer to TE domain (Liu et al., 2011). A-domain, large subdomain light green; small subdomain, dark green; C-terminal helix, blue;
PCP domain, yellow; PPant cofactor, red; C-domain, white; TE-domain, pink.
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As anticipated, crystals of this locked
chimeric protein reveal the EntE-derived
A-domain to be in the thiolation confor-
mation, with extensive contacts between
PCP helices I to III and both A-domain
subdomains (Figure 1C). Mapping the
contact region to the A-domain BasE
of acinetobactin biosynthesis allowed
generation of mutant variants able to
load substrate to EntB, confirming the
potential for engineering A-domain:PCP
contacts.
No major structural rearrangements of
the PCP domain are observed; surpris-
ingly, however, the C-terminal helix of
the EntE small subdomain is dissociated168 Chemistry & Biology 19, February 24, 201from the remainder of the A-domain.
Moreover, the chimeric protein crystal-
lizes as dimers so that the A-domain of
one monomer interacts with the PCP-
domain of the second, i.e., acts in trans.
Despite designing the linker based on
that in EntF, it is obvious that a cis interac-
tion would not be possible based on the
present structure. It seems likely that
a cis-transfer would require ‘‘melting’’ of
the A-domain C-terminal helix, which is
indeed apparent in the corresponding
SrfA-C termination module A-domain
(Tanovic et al. (2008); see Figure 1D).
In an alternative approach, Liu et al.
(2011) have utilized an a-chloroacetyl-
amino CoA analog to obtain a locked2 ª2012 Elsevier Ltd All rights reservedEntF-derived PCP-TE didomain. The
catalytically relevant interaction involves
PCP helices III and IV and residues of
the TE a/b core and helical lid. Only minor
domain rearrangements from the NMR
structure (Frueh et al., 2008) are ob-
served, suggesting that the PCP-TE
domains adopt a near-transfer orientation
in the absence of other domains. In
contrast, superposition with the structure
of SrfA-C (Figure 1E) hints that the PCP-
TE domains must reorient with respect
to the A- and C-domain platform, indi-
cating yet another degree of flexibility.
These studies demonstrate the impor-
tance of domain arrangement and con-
formational plasticity in the production
Chemistry & Biology
Previewsof nonribosomal peptides. The strategies
described by Liu et al. (2011) and Sundlov
et al. (2012) promise to lead to a better
understanding of the workings of these
complex and fascinating molecular
machines and serve as a first step in the
development of tailor-made NRPSs.
REFERENCES
Bruner, S.D., Weber, T., Kohli, R.M., Schwarzer,
D., Marahiel, M.A., Walsh, C.T., and Stubbs, M.T.
(2002). Structure 10, 301–310.Frueh, D.P., Arthanari, H., Koglin, A., Vosburg,
D.A., Bennett, A.E., Walsh, C.T., and Wagner, G.
(2008). Nature 454, 903–906.
Gulick, A.M. (2009). ACS Chem. Biol. 4, 811–827.
Koglin, A., Mofid, M.R., Lo¨hr, F., Scha¨fer, B., Ro-
gov, V.V., Blum, M.M., Mittag, T., Marahiel, M.A.,
Bernhard, F., and Do¨tsch, V. (2006). Science 312,
273–276.
Liu, Y., Zheng, T.F., and Bruner, S.D. (2011). Chem.
Biol. 18, 1482–1488.
May, J.J., Kessler, N., Marahiel, M.A., and Stubbs,
M.T. (2002). Proc. Natl. Acad. Sci. USA 99, 12120–
12125.Chemistry & Biology 19, February 24, 2012Strieker, M., Tanovic, A., and Marahiel, M.A.
(2010). Curr. Opin. Struct. Biol. 20, 234–240.Sundlov, J.A., Shi, C., Wilson, D.J., Aldrich, C.C.,
and Gulick, A.M. (2012). Chem. Biol. 19, this issue,
188–198.Tanovic, A., Samel, S.A., Essen, L.O., and Mara-
hiel, M.A. (2008). Science 321, 659–663.Yonus, H., Neumann, P., Zimmermann, S., May,
J.J., Marahiel, M.A., and Stubbs, M.T. (2008). J.
Biol. Chem. 283, 32484–32491.Exploiting Effectors of Rac GTPaseHakryul Jo1,* and Hongbo R. Luo2,*
1Environmental Health Sciences, Yale University School of Public Health, 7th Floor, 1 Church Street, New Haven, CT 06510, USA
2Department of Pathology and Laboratory medicine, Harvard Medical School and Children’s Hospital Boston, Enders Research Building,
Room 811 Boston, MA 02115, USA
*Correspondence: hakryul.jo@yale.edu (H.J.), hongbo.luo@childrens.harvard.edu (H.R.L.)
DOI 10.1016/j.chembiol.2012.02.001
Targeting a specific arm of signaling pathways is of great interest. In this issue ofChemistry & Biology, Bosco
et al. exploit the interactive interface between Rac GTPase and its effector p67phox to specifically inhibit reac-
tive oxygen species production without perturbing other Rac-mediated cellular processes.The coordinated assembly of multiprotein
complexes is essential for the transmission
of multiple downstream signaling path-
ways. Chemical tools that interfere with
the assembly of such complexes are highly
desirable to tease out the intracellular
signaling networks. Upon stimulation,
NADPH oxidase, a key cellular enzyme
responsible for generating the reactive
oxygen species (ROS), is assembled into
an active complex at the membrane. ROS
is the central weapon of phagocytes to
combat the invading microorganisms. It
also plays important regulatory functions
during neutrophil chemotaxis (Hattori
et al., 2010). Inefficient generation of ROS
due to genetic mutations of the compo-
nents of NADPH oxidase leads to chronic
granulomatous disease, which is typically
characterized by the inability to fight infec-
tion and aberrant inflammation. Beyond
their well-characterized traditionally roles
in innate immunity and inflammation,
more recently, ROS and NADPH oxidase
are actively being scrutinized as the key
mediators of a multitude of pathologicalconditions caused by oxidative stresses,
including neurological diseases, cardio-
vascular pathologies, and cancer (Bedard
and Krause, 2007; Kleinschnitz et al.,
2010; Williams and Griendling, 2007).
Accordingly, specific pharmacological
inhibitors of ROS production by NADPH
oxidase are being sought after for the ther-
apeutic benefits of various human patholo-
gies contributed by the oxidative stresses.
Targeting the assembly of active
NADPH oxidase complex is an efficient
way to inhibit ROS production. The
central components of active NADPH
oxidase consist of two membrane-bound
subunits, gp91phox (or Nox2) and p22phox,
four cytosolic proteins, p47phox, p67phox,
p40phox, and small GTPase Rac. In
response to external stimuli, the cytosolic
components are translocated to the
membrane and interact with the mem-
brane-bound components to assemble
an active NADPH complex, which then
transfer electrons from NADPH to oxygen
to generate the reactive superoxide anion
(Figure 1). A series of protein-proteininteractions are critical for an efficient
assembly of fully active NADPH oxidase
complex. For example, the C-terminal
part of cytosolic subunit p67phox interacts
with p47phox, while the N-terminal half of
p67phox is capable of binding to Rac.
The GTP-bound activated Rac recruits
p67phox to the membrane, hence facili-
tating the assembly of NADPH oxidase
complex and its activation. As demon-
strated by a small molecule inhibitor
(Gao et al., 2004), targeting Rac activity
is a legitimate strategy to interfere with
the assembly of NADPH complex and
ROS production. However, given the
pleiotropic regulatory functions of Rac in
a wide range of cellular functions, the
‘‘global’’ inhibition of Rac activity inevi-
tably comes with the risk of unintended
side effects, concomitant with inhibition
of ROS generation. On the other hand, the
‘‘pathway-selective’’ inhibition of down-
stream of Rac signaling may specifically
abrogateROSproductionwithout affecting
other Rac-dependent cellular processes.
Because the specific interactions betweenª2012 Elsevier Ltd All rights reserved 169
